EBR Systems Inc
ASX:EBR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Lanxess AG
XETRA:LXS
|
DE |
EBR Systems Inc
Stock-Based Compensation
EBR Systems Inc
Stock-Based Compensation Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Stock-Based Compensation | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
E
|
EBR Systems Inc
ASX:EBR
|
Stock-Based Compensation
$1.7m
|
CAGR 3-Years
32%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Stock-Based Compensation
$299m
|
CAGR 3-Years
11%
|
CAGR 5-Years
12%
|
CAGR 10-Years
11%
|
|
|
Stryker Corp
NYSE:SYK
|
Stock-Based Compensation
$243m
|
CAGR 3-Years
13%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Stock-Based Compensation
$664m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
Stock-Based Compensation
$60m
|
CAGR 3-Years
6%
|
CAGR 5-Years
14%
|
CAGR 10-Years
12%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Stock-Based Compensation
$788.2m
|
CAGR 3-Years
15%
|
CAGR 5-Years
15%
|
CAGR 10-Years
17%
|
|
EBR Systems Inc
Glance View
EBR Systems, Inc. engages in the development of implantable systems for wireless tissue stimulation. The company is headquartered in Sunnyvale, California. The company went IPO on 2021-11-24. The firm is engaged in developing and commercializing Wireless Stimulation Endocardially (WiSE), an implantable, cardiac pacing device able to provide stimulation to endocardial (inside the heart) heart tissue for the correction of heart rhythm conditions without requiring the use of leads. WiSE offers leadless solutions for LV Pacing, including cardiac resynchronization therapy (CRT) and conduction system pacing (CSP). The firm also offers CRT devices through the CRM subsegment under the brand names, including Visionist X4 CRT-P, Valitude X4 (CRT-P), Momentum CRT-D, Resonate X4 CRT-D, and Vigilant X4 CRT-D, among others. The firm operates various subsidiaries, which include EBR Systems (AUST) Pty. Ltd. and EBR Systems (UK) Limited, which establish clinical trials in Australia and the United Kingdom, respectively.
See Also
What is EBR Systems Inc's Stock-Based Compensation?
Stock-Based Compensation
869.6k
USD
Based on the financial report for Dec 31, 2022, EBR Systems Inc's Stock-Based Compensation amounts to 869.6k USD.
What is EBR Systems Inc's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 3Y
32%
Over the last year, the Stock-Based Compensation growth was 89%. The average annual Stock-Based Compensation growth rates for EBR Systems Inc have been 32% over the past three years .
